CN113171224B - An implanted bandage for promoting bone injury repair and preparation method thereof - Google Patents
An implanted bandage for promoting bone injury repair and preparation method thereof Download PDFInfo
- Publication number
- CN113171224B CN113171224B CN202110379089.7A CN202110379089A CN113171224B CN 113171224 B CN113171224 B CN 113171224B CN 202110379089 A CN202110379089 A CN 202110379089A CN 113171224 B CN113171224 B CN 113171224B
- Authority
- CN
- China
- Prior art keywords
- repair
- particles
- porous
- bandage material
- bone injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000008439 repair process Effects 0.000 title claims abstract description 78
- 206010061363 Skeletal injury Diseases 0.000 title claims abstract description 66
- 230000001737 promoting effect Effects 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 72
- 239000002245 particle Substances 0.000 claims abstract description 70
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 45
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 36
- 229920000642 polymer Polymers 0.000 claims abstract description 36
- 230000035876 healing Effects 0.000 claims abstract description 35
- 239000005312 bioglass Substances 0.000 claims abstract description 29
- 210000003460 periosteum Anatomy 0.000 claims abstract description 21
- 239000000835 fiber Substances 0.000 claims abstract description 20
- 210000003205 muscle Anatomy 0.000 claims abstract description 19
- 230000008929 regeneration Effects 0.000 claims abstract description 17
- 238000011069 regeneration method Methods 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 12
- 230000004054 inflammatory process Effects 0.000 claims abstract description 11
- 206010061218 Inflammation Diseases 0.000 claims abstract description 10
- 239000011521 glass Substances 0.000 claims abstract description 9
- 238000010146 3D printing Methods 0.000 claims abstract description 8
- 230000008569 process Effects 0.000 claims abstract description 4
- 238000010041 electrostatic spinning Methods 0.000 claims abstract 4
- 229920001410 Microfiber Polymers 0.000 claims description 39
- 238000009987 spinning Methods 0.000 claims description 30
- 239000011882 ultra-fine particle Substances 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 18
- 150000002500 ions Chemical class 0.000 claims description 17
- 239000007943 implant Substances 0.000 claims description 15
- 239000005416 organic matter Substances 0.000 claims description 15
- 239000011148 porous material Substances 0.000 claims description 14
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical group [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 239000001506 calcium phosphate Substances 0.000 claims description 7
- 238000007639 printing Methods 0.000 claims description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 7
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 6
- 235000011010 calcium phosphates Nutrition 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 5
- 239000011888 foil Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims description 5
- 239000004137 magnesium phosphate Substances 0.000 claims description 5
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims description 5
- 229960002261 magnesium phosphate Drugs 0.000 claims description 5
- 235000010994 magnesium phosphates Nutrition 0.000 claims description 5
- 235000012241 calcium silicate Nutrition 0.000 claims description 4
- ZPMRAKAWGWRPCB-UHFFFAOYSA-N calcium zinc silicate Chemical compound [Ca+2].[Zn+2].[O-][Si]([O-])([O-])[O-] ZPMRAKAWGWRPCB-UHFFFAOYSA-N 0.000 claims description 4
- FGZBFIYFJUAETR-UHFFFAOYSA-N calcium;magnesium;silicate Chemical compound [Mg+2].[Ca+2].[O-][Si]([O-])([O-])[O-] FGZBFIYFJUAETR-UHFFFAOYSA-N 0.000 claims description 4
- 239000011889 copper foil Substances 0.000 claims description 4
- 229910010272 inorganic material Inorganic materials 0.000 claims description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 3
- 239000000378 calcium silicate Substances 0.000 claims description 3
- 229910052918 calcium silicate Inorganic materials 0.000 claims description 3
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 3
- 238000002513 implantation Methods 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 238000003980 solgel method Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 claims description 3
- 229910000165 zinc phosphate Inorganic materials 0.000 claims description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 2
- 229910052810 boron oxide Inorganic materials 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 2
- 229910021645 metal ion Inorganic materials 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 229910020489 SiO3 Inorganic materials 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 claims 1
- 230000003467 diminishing effect Effects 0.000 claims 1
- 150000005837 radical ions Chemical class 0.000 claims 1
- 239000002131 composite material Substances 0.000 abstract description 30
- 210000001519 tissue Anatomy 0.000 abstract description 28
- 208000006735 Periostitis Diseases 0.000 abstract description 21
- 230000007547 defect Effects 0.000 abstract description 14
- 210000004872 soft tissue Anatomy 0.000 abstract description 8
- 208000015181 infectious disease Diseases 0.000 abstract description 7
- 230000015556 catabolic process Effects 0.000 abstract description 6
- 238000006731 degradation reaction Methods 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 3
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 244000053095 fungal pathogen Species 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 31
- 239000003658 microfiber Substances 0.000 description 24
- 208000027418 Wounds and injury Diseases 0.000 description 20
- 230000006378 damage Effects 0.000 description 19
- 238000001523 electrospinning Methods 0.000 description 17
- 206010052428 Wound Diseases 0.000 description 15
- 208000014674 injury Diseases 0.000 description 15
- 206010017076 Fracture Diseases 0.000 description 14
- 239000000203 mixture Substances 0.000 description 12
- 230000017423 tissue regeneration Effects 0.000 description 12
- 239000011734 sodium Substances 0.000 description 11
- 230000003110 anti-inflammatory effect Effects 0.000 description 10
- 229920000159 gelatin Polymers 0.000 description 10
- 239000008273 gelatin Substances 0.000 description 10
- 230000008733 trauma Effects 0.000 description 10
- 230000003111 delayed effect Effects 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 239000011701 zinc Substances 0.000 description 9
- 208000010392 Bone Fractures Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229910001410 inorganic ion Inorganic materials 0.000 description 8
- 239000011777 magnesium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 230000002195 synergetic effect Effects 0.000 description 8
- 229920001661 Chitosan Polymers 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 239000010949 copper Substances 0.000 description 7
- 230000028709 inflammatory response Effects 0.000 description 7
- 229910052749 magnesium Inorganic materials 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 229920000747 poly(lactic acid) Polymers 0.000 description 7
- 239000004626 polylactic acid Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 230000036770 blood supply Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 230000002924 anti-infective effect Effects 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 239000000391 magnesium silicate Substances 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 229920001610 polycaprolactone Polymers 0.000 description 5
- 239000004632 polycaprolactone Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 239000000783 alginic acid Substances 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 4
- 235000019792 magnesium silicate Nutrition 0.000 description 4
- 229910052919 magnesium silicate Inorganic materials 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 108010039918 Polylysine Proteins 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000003592 biomimetic effect Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 229940045110 chitosan Drugs 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 229960005188 collagen Drugs 0.000 description 3
- 230000001054 cortical effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940014259 gelatin Drugs 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000656 polylysine Polymers 0.000 description 3
- 229920002717 polyvinylpyridine Polymers 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 229910052712 strontium Inorganic materials 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 206010065687 Bone loss Diseases 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000003402 anti-promotion Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- -1 calcium (magnesium) silicate inorganic compound Chemical class 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 229910052809 inorganic oxide Inorganic materials 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229940005642 polystyrene sulfonic acid Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- 208000035967 Long Term Adverse Effects Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 206010041290 Soft tissue inflammation Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- VJNOZKSBNVMZON-UHFFFAOYSA-N [Ca].[Mg].[Si](O)(O)(O)O Chemical compound [Ca].[Mg].[Si](O)(O)(O)O VJNOZKSBNVMZON-UHFFFAOYSA-N 0.000 description 1
- LAZOHFXCELVBBV-UHFFFAOYSA-N [Mg].[Ca].[Si] Chemical compound [Mg].[Ca].[Si] LAZOHFXCELVBBV-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000922 anti-bactericidal effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940124605 anti-osteoporosis drug Drugs 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 210000003557 bones of lower extremity Anatomy 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 1
- 239000004068 calcium phosphate ceramic Substances 0.000 description 1
- NWXHSRDXUJENGJ-UHFFFAOYSA-N calcium;magnesium;dioxido(oxo)silane Chemical compound [Mg+2].[Ca+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O NWXHSRDXUJENGJ-UHFFFAOYSA-N 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 229910052637 diopside Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000003837 high-temperature calcination Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- MOWNZPNSYMGTMD-UHFFFAOYSA-N oxidoboron Chemical class O=[B] MOWNZPNSYMGTMD-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- MKTRXTLKNXLULX-UHFFFAOYSA-P pentacalcium;dioxido(oxo)silane;hydron;tetrahydrate Chemical compound [H+].[H+].O.O.O.O.[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O MKTRXTLKNXLULX-UHFFFAOYSA-P 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000010456 wollastonite Substances 0.000 description 1
- 229910052882 wollastonite Inorganic materials 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01012—Non-adhesive bandages or dressings characterised by the material being made of natural material, e.g. cellulose-, protein-, collagen-based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00548—Plasters form or structure net
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacturing & Machinery (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域technical field
本发明属于生物医用植入材料领域的一种植入绷带及制备方法,具体是涉及了一种促进骨损伤软、硬组织协同再生修复的植入型绷带材料及制备方法。The invention belongs to an implanted bandage in the field of biomedical implant materials and a preparation method, and particularly relates to an implanted bandage material and a preparation method for promoting the synergistic regeneration and repair of soft and hard tissues of bone injury.
背景技术Background technique
骨损伤通常包括骨折、骨缺损,后者又可称为骨创伤、骨缺失。在我国,每年有十万以上的人口规模死于因交通事故、跌落、砸伤、跌倒等意外事故所致的骨折或骨创伤,也有百万级的民众因各种手术、疾病、炎症造成骨缺损或者骨缺失,尤其是在中老年人各种慢性疾病和炎症造成骨损伤部位,血供差并且恢复缓慢,造成骨折延迟愈合、畸形愈合甚至不愈合(骨不连)。尽管常规的骨折治疗在临床已经形成的广泛的共识和经验,但是大量肌肉、骨膜损伤严重的肢体骨骨折、老年人髋部骨折,需要二次手术甚至致残、致死风险极高,迄今肢体骨的骨折延迟愈合发病率高达6%~10%,远高于人工假体感染的临床发生率。同时,肢体骨大段骨缺损的再生重建更是需要对血供恢复效率要求更高,骨膜损伤严重的骨创伤,需要相关治疗方法促进骨膜再生,为骨创伤提供种子干细胞和血供,因而是一项值得深入研究的重大问题。Bone injuries usually include fractures and bone defects, which may also be referred to as bone trauma and bone loss. In my country, more than 100,000 people die every year from fractures or bone trauma caused by accidents such as traffic accidents, falls, smashes, and falls. Defects or bone loss, especially in the middle-aged and elderly people at the site of bone damage caused by various chronic diseases and inflammation, have poor blood supply and slow recovery, resulting in delayed fracture union, malunion or even nonunion (nonunion). Although there is a broad consensus and experience in the clinical practice of conventional fracture treatment, a large number of limb bone fractures with severe muscle and periosteum damage, and hip fractures in the elderly require a second operation or even become disabled and have a high risk of death. The incidence of delayed union of fractures is as high as 6% to 10%, which is much higher than the clinical incidence of artificial prosthesis infection. At the same time, the regeneration and reconstruction of large segmental bone defects in the limbs requires higher blood supply recovery efficiency. Bone trauma with severe periosteal damage requires related treatment methods to promote periosteal regeneration and provide seed stem cells and blood supply for bone trauma. A major question worthy of in-depth study.
目前常用的骨折护理和促进骨创伤修复的包括外用帮带、金属支架或者植入钢板、髓内钉、人工骨、自体骨等等,并会采用抗感染和抗炎症药物、缓解骨质疏松药物、促进骨损伤修复的营养品、中草药等在围手术期进行辅助治疗。对于骨膜损伤严重的患者,还通过骨膜移植等解决血供问题。不过,这些常规的骨损伤修复治疗中往往忽视了肌肉、骨膜损伤以及由此带来的软组织炎症对骨折端愈合产生的不利影响。近年来,人们更加重视仿生骨膜的基础研究和开发,大量基于水凝胶、电纺纤维薄膜或者脱细胞外基质被用于骨膜组织工程的支架载体,并研究骨髓间充质干细胞、骨膜源干细胞在这些仿生基质材料上生长并促进血管化和成骨的功能特点。遗憾的是,人们还是忽视了软、硬组织内炎症反应、细菌性感染等潜在问题对骨损伤延迟愈合、修复的作用和影响,尤其是中老年人骨质疏松、糖尿病、股骨头坏死等骨骼疾病和代谢能力显著下降对骨折愈合效率的不利影响。因此,亟待研究开发骨膜严重受损丢失、肌肉严重受损的骨折和骨创伤治疗中,或者肌肉覆盖量极为有限的肢体骨折、骨缺损问题的高效愈合修复问题的新材料。At present, the commonly used fracture care and bone trauma repair include external support belts, metal stents or implanted steel plates, intramedullary nails, artificial bone, autologous bone, etc., and anti-infective and anti-inflammatory drugs, and osteoporosis drugs are used. , Nutrients and Chinese herbal medicines to promote bone damage repair are used as adjuvant therapy in the perioperative period. For patients with severe periosteal damage, blood supply problems can also be solved through periosteal transplantation. However, the adverse effects of muscle and periosteal injury and the resulting soft tissue inflammation on fracture healing are often overlooked in these conventional bone injury repair treatments. In recent years, people have paid more attention to the basic research and development of biomimetic periosteum. A large number of scaffolds based on hydrogels, electrospun fiber membranes or acellular extracellular matrix have been used as scaffolds for periosteal tissue engineering. Grow on these biomimetic matrix materials and promote the functional features of vascularization and osteogenesis. Unfortunately, people still ignore the role and impact of potential problems such as inflammatory responses in soft and hard tissues and bacterial infections on delayed healing and repair of bone injuries, especially in the middle-aged and elderly, such as osteoporosis, diabetes, and femoral head necrosis. Disease and markedly reduced metabolic capacity adversely affect fracture healing efficiency. Therefore, it is urgent to research and develop new materials for the treatment of fractures and bone trauma with severely damaged periosteum and severely damaged muscles, or for limb fractures and bone defects with extremely limited muscle coverage.
据此,促进骨损伤修复的新材料,必然要求对损伤部位软、硬组织的创面实现同步干预和调控,尤其是解决三个方面的问题:Accordingly, new materials to promote bone injury repair must require simultaneous intervention and regulation of the soft and hard tissue wounds at the injury site, especially to solve three problems:
一是肌肉组织创伤引起的持续炎症反应可能对骨损伤内修复产生不利影响,以及肌肉创伤需要及时愈合并且防控感染的问题。First, the persistent inflammatory response caused by muscle tissue trauma may adversely affect the internal repair of bone injury, and the need for timely healing of muscle trauma and infection prevention and control.
二是骨膜损毁后骨缺损内血供收到严重影响,骨膜自身重建修复过程并不能给与骨损伤修复提供营养供给方面的积极支撑,以及骨膜源干细胞缺失也会危及骨损伤愈合效率的改善。Second, the blood supply in the bone defect is seriously affected after the periosteum is damaged. The reconstruction and repair process of the periosteum itself cannot provide positive support in terms of nutrient supply for the repair of bone damage, and the lack of periosteum-derived stem cells will also jeopardize the improvement of the healing efficiency of bone damage.
三是病理性骨骼内骨损伤快速修复的活性刺激需要外部供给,并避免软组织创伤的慢性炎症参与到骨缺损断端细胞与分子生物学过程,不利于血管再生及软骨性骨痂形成问题。Third, the active stimulation of rapid repair of pathological skeletal bone injury requires external supply, and to avoid chronic inflammation of soft tissue trauma from participating in the cellular and molecular biological processes at the broken end of the bone defect, which is not conducive to angiogenesis and cartilage callus formation.
因此,对这类骨损伤问题的干预治疗,不能仅仅依赖于口服、静脉注射或者仿生性组织工程化骨膜植入,必须建立基于软硬组织感染、炎症和新生组织便于生长的基质并协同修复三个方面协同的多功能化植入物进行高效介导作用,才能够解决临床不少骨损伤延迟愈合、畸形愈合等问题。Therefore, the intervention and treatment of this type of bone injury cannot only rely on oral, intravenous injection or biomimetic tissue-engineered periosteal implantation. It is necessary to establish a matrix based on soft and hard tissue infection, inflammation and new tissue to facilitate the growth and synergistic repair of the three The efficient mediation of multifunctional implants with synergistic aspects of each aspect can solve many clinical problems such as delayed healing and malunion of bone injuries.
近年来的研究发现一些无机氧化物构建的非晶玻璃态材料或者无机离子对各种细菌具有显著抑制甚至杀灭效果,能够调节免疫细胞活性,介导炎症反应向组织修复方向发展,并且还可以促进血管化和皮肤、骨膜等软组织再生愈合。譬如大量研究发现铜、锌离子能够抑制和杀灭创伤中的有害细菌,并具有广谱杀菌性能。同时,锌、镁等离子还可以调节免疫细胞的炎性因子表达,具有抗炎效果;并且铜、镁离子可以调节血管内皮细胞活性及血管化生长因子的高效表达,从而显示出优良的促进血管化效果。其次,人们也相继证实,一些可降解的钙磷酸盐、钙(镁)硅酸盐无机化合物材料能够促进骨组织再生修复,掺杂锌、镁、铜等无机离子后具有抗炎和杀菌等多功能性。因此,通过构建具有抗炎、防感染并促进软、硬组织同步再生修复的骨折治疗材料解决临床棘手问题是可行的。In recent years, studies have found that some amorphous glass materials constructed of inorganic oxides or inorganic ions have a significant inhibitory or even killing effect on various bacteria, can regulate the activity of immune cells, mediate the development of inflammatory responses towards tissue repair, and can also Promote vascularization and regeneration and healing of soft tissues such as skin and periosteum. For example, a large number of studies have found that copper and zinc ions can inhibit and kill harmful bacteria in wounds, and have broad-spectrum bactericidal properties. At the same time, zinc, magnesium and other ions can also regulate the expression of inflammatory factors in immune cells, and have anti-inflammatory effects; and copper and magnesium ions can regulate the activity of vascular endothelial cells and the high expression of vascularization growth factors, thus showing excellent promotion of vascularization. Effect. Secondly, it has also been confirmed that some degradable calcium phosphate and calcium (magnesium) silicate inorganic compound materials can promote bone tissue regeneration and repair, and have anti-inflammatory and bactericidal properties after doping with inorganic ions such as zinc, magnesium and copper. Feature. Therefore, it is feasible to solve difficult clinical problems by constructing fracture treatment materials with anti-inflammatory, anti-infection and promotion of synchronous regeneration and repair of soft and hard tissues.
根据现有技术研究来看,迫切需要创建在化学组成、微纳结构、理化性能、力学性能(涉及到手术植入的可操控性及术后较长时期内结构稳定性)以及生物学效应上均满足临床上人体内多种骨损伤高效愈合修复的多功能性植入绷带材料,这样的材料不仅具备在细胞、分子水平上实现对人体细胞的相容性,并主动调控血管化、肌肉、骨膜、骨骼等软、硬组织再生,同时材料的微结构有利于营养传输且有利于组织再生修复粘附、生长。因此,只有在化学组成、微结构、功能上通过创新设计和优化构建,才能成为新一代促进骨损伤修复的植入绷带材料,解决大量临床骨损伤延迟愈合、不修复等的风险问题。According to the existing technical research, there is an urgent need to create research on chemical composition, micro-nano structure, physical and chemical properties, mechanical properties (involving the maneuverability of surgical implantation and structural stability for a long period of time after surgery) and biological effects. It is a multifunctional implant bandage material that can effectively heal and repair various bone injuries in the human body in clinical practice. Such materials not only have compatibility with human cells at the cellular and molecular levels, but also actively regulate vascularization, muscle, Soft and hard tissues such as periosteum and bones are regenerated, and the microstructure of the material is conducive to nutrient transmission and tissue regeneration, repair, adhesion and growth. Therefore, only through innovative design and optimized construction in terms of chemical composition, microstructure and function can it become a new generation of implanted bandage materials that promote bone injury repair, and solve the risk of delayed healing and non-repair of a large number of clinical bone injuries.
根据现有专利技术、研究文献报道以及临床应用来看,迫切需要设计能促进骨损伤修复的植入绷带,这样的促进骨损伤修复的植入绷带需要具备的功能和功效包括:According to the existing patent technology, research literature reports and clinical applications, it is urgent to design an implanted bandage that can promote the repair of bone injury. The functions and efficacy of such an implanted bandage that promotes the repair of bone injury include:
1)在创面清洗不彻底或者其它组织器官细菌迁移到创面也能保持不被感染;1) Even if the wound surface is not cleaned thoroughly or the bacteria of other tissues and organs migrate to the wound surface, it can remain uninfected;
2)具有良好的手术可塑性和操作性,并在骨损伤愈合的早期阶段发生显著性多功能协同性能;2) It has good surgical plasticity and operability, and has significant multifunctional synergistic performance in the early stage of bone injury healing;
3)能快速、有效地控制感染,抑制慢性炎症发展,促使炎性反应向组织再生方向发展;3) It can quickly and effectively control infection, inhibit the development of chronic inflammation, and promote the development of inflammatory response in the direction of tissue regeneration;
4)促进血管化;4) Promote vascularization;
5)对骨损伤断端具有刺激成骨活性;5) Stimulating osteogenic activity on broken ends of bone injury;
6)能成为骨膜再生的基质(支架)并促进骨膜再生重建;6) It can become a matrix (scaffold) for periosteal regeneration and promote periosteal regeneration and reconstruction;
7)价格经济,易于广泛流通和配备;7) Economical price, easy to widely circulate and equip;
8)无副作用,不对伤口组织造成新损伤,具有优良的生物相容性,在骨损伤修复和骨痂改建完成时基本完成降解吸收。8) No side effects, no new damage to wound tissue, excellent biocompatibility, and basically complete degradation and absorption when bone damage repair and callus reconstruction are completed.
发明内容SUMMARY OF THE INVENTION
为了解决背景技术中缺失的技术空白,本发明提出了一种促进骨损伤修复的植入绷带材料及制备方法,片状多孔性网格聚合物材料两个面分别由有机-无机复合超细纤维膜覆盖的绷带型材料,用于促进骨损伤修复并防控各种副反应,弥补了现有技术的严重缺陷和不足。In order to solve the missing technical gap in the background technology, the present invention proposes an implanted bandage material and a preparation method for promoting the repair of bone injury. The film-covered bandage-type material is used to promote bone injury repair and prevent and control various side effects, making up for the serious defects and deficiencies of the prior art.
本发明是两种多功能性无机超细颗粒材料被整合到二维多孔网格两个表面,通过其降解释放多种活性离子组合物解决骨损伤创面中软、硬组织愈合中的功能需求。In the present invention, two multifunctional inorganic ultrafine particle materials are integrated into two surfaces of a two-dimensional porous grid, and a variety of active ion compositions are released through their degradation to solve the functional requirements of soft and hard tissue healing in bone injury wounds.
本发明促进骨损伤修复的植入绷带材料在与创面接触后,与骨缺损和肌肉分别接触面的纤维网络中的超细微粒均会释放多元无机离子组合物并引起局部消炎、抗感染以及促进血管化和组织再生修复功效,对各类严重骨损伤损伤具有优良促进愈合修复功效。After the implanted bandage material for promoting the repair of bone damage of the present invention is in contact with the wound surface, the ultrafine particles in the fibrous network on the contact surfaces of the bone defect and the muscle will release the multi-component inorganic ion composition and cause local anti-inflammatory, anti-infection and promotion. It has excellent vascularization and tissue regeneration and repair effects, and has excellent healing and repair effects on various types of severe bone injuries.
本发明促进骨损伤修复的植入绷带材料既解决了快速消炎、高效抑菌、促进肌肉、骨膜再生以及骨折断端愈合修复等多种功能,还解决了可操作性简便、完全降解吸收等问题,从而达到理想的促进骨损伤修复的标准,为解决临床问题提供了优越的新型促进骨损伤修复的植入绷带材料。The implanted bandage material for promoting bone injury repair of the invention not only solves various functions such as rapid anti-inflammatory, high-efficiency bacteriostasis, promotion of muscle and periosteum regeneration, and healing and repair of fractured ends, but also solves the problems of simple operability, complete degradation and absorption, etc. , so as to achieve the ideal standard of promoting bone injury repair, and provide an excellent new implant bandage material for promoting bone injury repair for solving clinical problems.
本发明采用的技术方案是:The technical scheme adopted in the present invention is:
一、一种促进骨损伤修复的植入绷带材料:1. An implanted bandage material for promoting bone injury repair:
所述促进骨损伤修复的植入绷带材料为多层化多孔网络结构,下层主要由含生物玻璃微粒的超细纤维多孔网络构成,中间层主要由聚合物多孔网格构成,上层主要由含无机矿物微粒的超细纤维多孔网络构成,纤维多孔网络和聚合物多孔网格的孔道分别为0.30~1200μm和200~1800μm水平。The implanted bandage material for promoting bone damage repair is a multi-layered porous network structure, the lower layer is mainly composed of a microfiber porous network containing biological glass particles, the middle layer is mainly composed of polymer porous meshes, and the upper layer is mainly composed of inorganic materials. The mineral particles are composed of a microfiber porous network, and the pore channels of the fiber porous network and the polymer porous network are respectively 0.30-1200 μm and 200-1800 μm.
上述的超细是指纳米到数十微米级直径的纤维。The above-mentioned ultrafine refers to fibers with a diameter of nanometer to tens of micrometers.
所述的生物玻璃微粒的粒度为0.04~8μm,所述的无机矿物微粒的颗粒度为0.02~20μm。The particle size of the biological glass particles is 0.04-8 μm, and the particle size of the inorganic mineral particles is 0.02-20 μm.
所述的超细纤维是指胶原蛋白、壳聚糖、海藻酸、透明质酸、明胶、聚乙二醇、聚乳酸、羧甲基壳聚糖、聚烯丙基铵盐酸盐、聚乙烯亚胺、聚乙烯胺、聚乙烯吡啶和多聚赖氨酸中的一种有机物或者几者任意间的复合物,超细纤维的直径为0.10~20μm;The superfine fiber refers to collagen, chitosan, alginic acid, hyaluronic acid, gelatin, polyethylene glycol, polylactic acid, carboxymethyl chitosan, polyallyl ammonium hydrochloride, polyethylene An organic substance or a composite of any of them among imine, polyvinylamine, polyvinylpyridine and polylysine, and the diameter of the ultrafine fiber is 0.10-20 μm;
所述的聚合物多孔网格是指聚乳酸、聚乳酸-羟基乙酸共聚物、聚己内酯、聚L-丙交酯-己内酯、海藻酸钠、透明质酸、硫酸软骨素、聚甲基丙烯酸、硫酸葡聚糖、羧甲基纤维素钠、纤维素、聚丙烯酸、聚苯乙烯磺酸、聚乙烯磺酸和聚乙烯磷酸中的一种有机物或者几者任意间的复合物,网格骨架纤维的截面形态没有严格限制,截面尺度为100~1200μm。The polymer porous mesh refers to polylactic acid, polylactic acid-co-glycolic acid copolymer, polycaprolactone, poly-L-lactide-caprolactone, sodium alginate, hyaluronic acid, chondroitin sulfate, poly An organic substance or a complex between any of them in methacrylic acid, dextran sulfate, sodium carboxymethyl cellulose, cellulose, polyacrylic acid, polystyrene sulfonic acid, polyvinyl sulfonic acid and polyvinyl phosphoric acid, The cross-sectional shape of the mesh skeleton fiber is not strictly limited, and the cross-sectional dimension is 100-1200 μm.
所述的生物玻璃微粒是以由添加介孔结构导向剂采用溶胶-凝胶方法制备的硅氧化物和硼氧化物为介孔结构骨架,介孔结构骨架中添加多元氧化物,多元氧化物在介孔结构骨架中杂化为全玻璃态或部分玻璃态物质而形成,主要成分为SiO2-B2O3-CaO-MgO。The bioglass particles are mesoporous structure skeletons prepared by adding mesoporous structure directing agents using silicon oxides and boron oxides by a sol-gel method, and multi-component oxides are added to the mesoporous structure skeletons. The mesoporous structure skeleton is formed by hybridization of all glassy or partial glassy substances, and the main components are SiO 2 -B 2 O 3 -CaO-MgO.
所述的生物玻璃微粒中还含有CuO、ZnO、Na2O和K2O、P2O5其中的一种或者多种。The bioglass particles also contain one or more of CuO, ZnO, Na 2 O, K 2 O, and P 2 O 5 .
所述的生物玻璃微粒中各组分的摩尔份数为:The molar fraction of each component in the bioglass particles is:
SiO2 24~60份24~60 parts of SiO 2
B2O3 4~30份B 2 O 3 4~30 parts
CaO 12~36份CaO 12~36 parts
MgO 1~12份1 to 12 parts of MgO
CuO 0.4~8份CuO 0.4 to 8 parts
ZnO 0~8份0~8 parts of ZnO
Na2O 0~8份Na 2 O 0~8 parts
K2O 0~12份K 2 O 0 to 12 parts
P2O5 0~16份。P 2 O 5 0-16 parts.
所述的无机矿物微粒的主要成分为钙磷酸盐、钙硅酸盐、钙镁硅酸盐、钙-锌硅酸盐、镁硅酸盐、镁磷酸盐、锌磷酸盐物质。The main components of the inorganic mineral particles are calcium phosphate, calcium silicate, calcium magnesium silicate, calcium-zinc silicate, magnesium silicate, magnesium phosphate, and zinc phosphate substances.
所述的无机矿物微粒还含有Cu2+、Zn2+、Sr2+和Na+离子其中的一种或者多种掺杂离子。The inorganic mineral particles also contain one or more doping ions among Cu 2+ , Zn 2+ , Sr 2+ and Na + ions.
所述的无机矿物微粒中各无机金属离子和酸根离子的摩尔份数为:The molar fraction of each inorganic metal ion and acid ion in the inorganic mineral particles is:
SiO3 2-/PO4 3-1~54份1~54 parts of SiO 3 2- /PO 4 3-
Ca2+1~60份Ca 2+ 1~60 servings
Mg2+0~52份Mg 2+ 0~52 parts
Zn2+0~20份0~20 parts of Zn 2+
Cu2+0.6~6份Cu 2+ 0.6~6 servings
Sr2+0~12份Sr 2+ 0~12 parts
Na+0~8份Na + 0~8 servings
其余为结晶水。The rest is crystal water.
上述SiO3 2-/PO4 3-表示SiO3 2-和PO4 3-中的其中一种或者混合。The above-mentioned SiO 3 2- /PO 4 3- represents one or a mixture of SiO 3 2- and PO 4 3- .
本发明是采用湿化学合成、溶胶-凝胶法、高温煅烧制备的钙磷酸盐、钙硅酸盐、钙镁硅酸盐、钙-锌硅酸盐、镁硅酸盐、镁磷酸盐、锌磷酸盐物质为主提矿物质,将镁、锌、铜、锶、钠进行异质离子掺杂的部分结晶和全结晶物质。The present invention adopts wet chemical synthesis, sol-gel method and high temperature calcination to prepare calcium phosphate, calcium silicate, calcium magnesium silicate, calcium-zinc silicate, magnesium silicate, magnesium phosphate, zinc Phosphate substances are the main minerals, partially crystalline and fully crystalline substances doped with magnesium, zinc, copper, strontium, and sodium by heterogeneous ions.
所述的无机矿物微粒中的钙磷酸盐为羟基磷灰石、无水磷酸钙、二水磷酸氢钙、磷酸四钙、磷酸八钙、磷酸三钙中的一种或多种。The calcium phosphate in the inorganic mineral particles is one or more of hydroxyapatite, calcium phosphate anhydrous, calcium hydrogen phosphate dihydrate, tetracalcium phosphate, octacalcium phosphate, and tricalcium phosphate.
所述的无机矿物微粒中的钙硅酸盐和钙镁硅酸盐为硅灰石、白硅钙石、锌黄长石、镁黄长石、透辉石中的一种或多种。The calcium silicates and calcium magnesium silicates in the inorganic mineral particles are one or more of wollastonite, tobermorite, kaffirite, kaffirite, and diopside.
所述的钙-锌硅酸盐为锌黄长石。The calcium-zinc silicate is kesterite.
所述的镁硅酸盐和镁磷酸盐为硅酸镁和磷酸镁。The magnesium silicate and magnesium phosphate are magnesium silicate and magnesium phosphate.
二、一种促进骨损伤修复的植入绷带材料的制备方法,包括以下步骤:2. A preparation method of an implanted bandage material for promoting bone injury repair, comprising the following steps:
1)将生物玻璃微粒加入到有机物溶液中搅拌均匀,生物玻璃微粒与溶液中有机物的质量比为1:(2~80),配制成超细颗粒物浓度为1~100mg/ml的有机-无机复合物溶液,然后转移到静电纺丝的储液器中,设置纺丝间距为5~18cm,在纺丝电压为4~20kV下,按0.10~0.8毫升/小时的速度进行静电纺丝,然后收集储液器的接收载体上厚度为10~400微米水平的超细纤维多孔薄膜;1) Add the bio-glass particles to the organic solution and stir evenly. The mass ratio of the bio-glass particles to the organic substances in the solution is 1: (2-80), and the organic-inorganic composite with the ultra-fine particle concentration of 1-100 mg/ml is prepared. Then transfer to the liquid reservoir for electrospinning, set the spinning distance to 5-18 cm, and perform electrospinning at a speed of 0.10-0.8 ml/hour under the spinning voltage of 4-20 kV, and then collect A microfiber porous film with a thickness of 10 to 400 microns on the receiving carrier of the liquid reservoir;
2)将用于制备聚合物多孔网格的有机物直接置入三维打印机的物料器中,采用加热软化有机物的聚合物并进行挤压出打印喷头,以步骤1)形成的超细纤维多孔薄膜为基质在上表面进行三维打印聚合物多孔网格;2) The organic matter used for preparing the polymer porous grid is directly placed in the material container of the three-dimensional printer, and the polymer of the organic matter is heated and softened and extruded out of the printing nozzle, and the microfiber porous film formed in step 1) is used as The matrix is 3D printed polymer porous mesh on the upper surface;
3)将无机矿物微粒加入到有机物溶液中搅拌均匀,无机矿物微粒与溶液中有机物的质量比为1:(2~80),配制成超细颗粒物浓度为1~100mg/ml的复合物溶液,然后进行复合物溶液静电纺丝,将超细纤维沉积在步骤2)制备的聚合物多孔网格上表面,纺丝间距为4~15cm,纺丝电压为4~20kV,纺丝速度为0.10~1.0毫升/小时,形成厚度为10~800微米的植入绷带材料。3) Add the inorganic mineral particles to the organic solution and stir evenly. The mass ratio of the inorganic mineral particles to the organic matter in the solution is 1:(2~80), and the compound solution with the ultrafine particle concentration of 1~100mg/ml is prepared. Then electrospin the composite solution, deposit the ultrafine fibers on the upper surface of the polymer porous grid prepared in step 2), the spinning distance is 4-15 cm, the spinning voltage is 4-20 kV, and the spinning speed is 0.10- 1.0 ml/hour to form an implanted bandage material with a thickness of 10-800 microns.
所述的有机物溶液为胶原蛋白、壳聚糖、海藻酸、透明质酸、明胶、聚乙二醇、聚乳酸、羧甲基壳聚糖、聚烯丙基铵盐酸盐、聚乙烯亚胺、聚乙烯胺、聚乙烯吡啶和多聚赖氨酸中的一种有机物或者几者任意间的复合物的溶液。The organic solution is collagen, chitosan, alginic acid, hyaluronic acid, gelatin, polyethylene glycol, polylactic acid, carboxymethyl chitosan, polyallylammonium hydrochloride, polyethyleneimine , polyvinylamine, polyvinylpyridine and polylysine, an organic compound or a solution of any complex between them.
所说的接收载体为多孔性金属铝箔或铜箔,孔道为三角形、四边形、六边形、圆形、蜂窝形中的任意一种或者两种的组合,孔尺度为0.3~2000微米。The receiving carrier is porous metal aluminum foil or copper foil, the pores are any one of triangle, quadrangle, hexagon, circle and honeycomb or a combination of the two, and the pore size is 0.3-2000 microns.
所说的多孔网格的孔形态没有严格限制,孔形态可以是圆形、四边形、六边形、椭圆形中的一种或者任意两者的组合,但所述的网格的孔尺度为50~850微米,聚合物多孔网格的厚度为200~1200微米。The pore shape of the porous grid is not strictly limited, and the pore shape can be one of a circle, a quadrilateral, a hexagon, an ellipse, or a combination of any two, but the pore size of the grid is 50. ~850 microns, and the thickness of the polymer porous grid is 200 to 1200 microns.
所述促进骨损伤修复的植入绷带材料在自主消炎、自主抗菌并促进肌肉组织、骨膜组织和骨组织高效愈合或者再生修复中的应用。The application of the implanted bandage material for promoting bone injury repair in autonomous anti-inflammatory, autonomous antibacterial and promoting efficient healing or regeneration of muscle tissue, periosteum tissue and bone tissue.
本发明所述促进骨损伤修复的植入绷带材料应用于促进各类骨膜、肌肉损伤严重的骨折或者骨缺损的愈合和修复领域。The implanted bandage material for promoting bone injury repair of the present invention is used in the field of promoting the healing and repair of various types of periosteum and severe muscle injury fractures or bone defects.
本发明所述促进骨损伤修复的植入绷带材料的应用,其特征在于绷带进行多层化构建,以聚合物多孔网格作为载体解决力学支撑问题,含生物玻璃微粒的超细纤维多孔网络和含无机矿物微粒的超细纤维多孔网络分别对聚合物多孔网格的两个表面进行修饰改性,从而确保与肌肉接触的一面和与骨创面接触的一面通过不同的化学成分调控不同的多功能性,从而兼顾损伤部位软、硬组织协同干预和有效调节炎症反应和防治感染,并协同促进软、硬组织再生和修复。The application of the implanted bandage material for promoting bone injury repair of the present invention is characterized in that the bandage is constructed in multiple layers, and the polymer porous grid is used as a carrier to solve the problem of mechanical support, and the ultra-fine fiber porous network containing biological glass particles and The microfiber porous network containing inorganic mineral particles modifies the two surfaces of the polymer porous grid respectively, so as to ensure that the side in contact with the muscle and the side in contact with the bone wound can be controlled by different chemical components. Therefore, it can take into account the synergistic intervention of soft and hard tissues at the injury site, effectively regulate the inflammatory response and prevent infection, and synergistically promote the regeneration and repair of soft and hard tissues.
本发明所述促进骨损伤修复的植入绷带材料的应用,解决了长期以来骨膜、肌肉受损严重下软组织持续炎症对损伤早期愈合的不良影响,以及软组织自身修复缓慢造成骨损伤部位血供差,引起骨损伤延迟愈合、不修复和畸形修复等严重问题,同时还解决了骨损伤部位因清创不彻底或者继发细菌感染导致的骨损伤愈合修复延迟问题。The application of the implanted bandage material for promoting bone injury repair of the present invention solves the long-term adverse effects of persistent inflammation of soft tissue under severe damage to periosteum and muscle on the early healing of injury, and the slow self-repair of soft tissue causes poor blood supply at the site of bone injury , causing serious problems such as delayed healing, non-repair and deformity repair of bone injury, and also solved the problem of delayed healing and repair of bone injury caused by incomplete debridement or secondary bacterial infection at the bone injury site.
本发明所述的促进骨损伤修复的植入绷带材料,生物玻璃微粒中具有特殊的无机氧化物,有利于维持和提高其生物相容性、消炎、抗菌和促进肌肉、骨膜再生修复。The implanted bandage material for promoting bone damage repair of the present invention has special inorganic oxides in the bioglass particles, which is beneficial to maintain and improve its biocompatibility, anti-inflammatory, antibacterial, and promote muscle and periosteum regeneration and repair.
本发明所述的促进骨损伤修复的植入绷带材料,无机矿物微粒中掺杂无机离子,有利于维持和提高其生物相容性、控制炎症反应、抗菌和促进骨损伤愈合、修复。The implanted bandage material for promoting bone injury repair of the present invention is doped with inorganic ions in inorganic mineral particles, which is beneficial to maintain and improve its biocompatibility, control inflammatory response, antibacterial and promote bone injury healing and repair.
本发明所述的促进骨损伤修复的植入绷带材料,表面进行二次修饰,有利于提高抗炎、抗感染和组织愈合效率的有机、无机分子或离子。The implanted bandage material for promoting bone injury repair according to the present invention has secondary modification on the surface, which is beneficial to organic and inorganic molecules or ions that improve the efficiency of anti-inflammatory, anti-infection and tissue healing.
本发明所述的促进骨损伤修复的植入绷带材料,生物玻璃微粒中介孔结构形态没有严格限制,可以是四方孔、六方孔或者二者的复合结构。The implanted bandage material for promoting bone injury repair according to the present invention has no strict limitation on the structure of the mesopore structure of the bioglass particles, and can be a square hole, a hexagonal hole or a composite structure of the two.
本发明所述的超细纤维多孔膜的有机物是指胶原蛋白、壳聚糖、海藻酸、透明质酸、明胶、聚乙二醇、聚乳酸、羧甲基壳聚糖、聚烯丙基铵盐酸盐、聚乙烯亚胺、聚乙烯胺、聚乙烯吡啶和多聚赖氨酸中的一种有机物或者几者任意间的复合物构成。The organic matter of the superfine fiber porous membrane of the present invention refers to collagen, chitosan, alginic acid, hyaluronic acid, gelatin, polyethylene glycol, polylactic acid, carboxymethyl chitosan, polyallyl ammonium It is composed of an organic compound or any combination of them among hydrochloride, polyethyleneimine, polyvinylamine, polyvinylpyridine and polylysine.
本发明所述的聚合物多孔网格是由聚乳酸、聚乳酸-羟基乙酸共聚物、聚己内酯、聚L-丙交酯-己内酯、海藻酸钠、透明质酸、硫酸软骨素、聚甲基丙烯酸、硫酸葡聚糖、羧甲基纤维素钠、纤维素、聚丙烯酸、聚苯乙烯磺酸、聚乙烯磺酸和聚乙烯磷酸中的一种有机物或者几者任意间的复合物构成。The polymer porous grid of the present invention is made of polylactic acid, polylactic acid-glycolic acid copolymer, polycaprolactone, poly-L-lactide-caprolactone, sodium alginate, hyaluronic acid, chondroitin sulfate , polymethacrylic acid, dextran sulfate, sodium carboxymethyl cellulose, cellulose, polyacrylic acid, polystyrene sulfonic acid, polyvinyl sulfonic acid and polyvinyl phosphoric acid. composition.
本发明所述的促进骨损伤修复的植入绷带材料,对绷带中二维片状聚合物多孔网格两个表面上超细纤维多孔网络的形态没有严格限制,也可以是多孔薄膜、多孔海绵,以有利于骨损伤部位软、硬组织创伤的覆盖和创面愈合的需求。The implanted bandage material for promoting bone injury repair according to the present invention has no strict restrictions on the morphology of the ultra-fine fiber porous network on the two surfaces of the two-dimensional sheet-like polymer porous grid in the bandage, and can also be a porous film, a porous sponge , in order to facilitate the coverage of soft and hard tissue wounds at the site of bone injury and the needs of wound healing.
本发明所述的促进骨损伤修复的植入绷带材料,对多层化的多孔结构复合的制备工艺可以是各种三维打印工艺制备,也可以是相分离法、冻干法、微颗粒造孔法制备,所形成的三层复合材料均属于本发明所述的促进骨损伤修复的植入绷带材料范畴。The implanted bandage material for promoting the repair of bone injury according to the present invention can be prepared by various three-dimensional printing processes for the composite preparation process of the multi-layered porous structure, or can be prepared by a phase separation method, a freeze-drying method, or a micro-particle pore forming method. The three-layer composite materials formed belong to the category of implanted bandage materials for promoting bone injury repair according to the present invention.
本发明所述的促进骨损伤修复的植入绷带材料,对应用范围不存在严格限制,可以在人体任意骨骼的骨创伤愈合、修复治疗中促进受损软、硬组织协同修复的应用,也可以用于牙周骨组织愈合并避免软组织长入和隔离。The implanted bandage material for promoting the repair of bone damage according to the present invention has no strict limitation on the scope of application, and can be used for promoting the synergistic repair of damaged soft and hard tissues in the healing and repairing of any bone in the human body, and can also For periodontal bone healing and avoiding soft tissue ingrowth and isolation.
上述可见,本发明绷带由多孔网格片状物及其两侧表面被有机-无机复合超细纤维多孔薄膜覆盖物构成,两侧表面超细纤维中的无机物分别为抑制炎症、抗感染并促进软组织再生修复的生物玻璃微粒和抑制炎症并促进骨再生修复的无机矿物微粒组成,绷带通过三维打印、静电纺丝工艺制备,操作方便,对各种骨折或骨缺损的肌肉、骨膜、骨骼等软、硬组织内的炎症具有显著抑制效果,并促进软、硬组织快速愈合并修复,植入型绷带的降解速率可调控,并对常见病原菌、真菌有显著抑菌作用。It can be seen from the above that the bandage of the present invention is composed of a porous mesh sheet and the surfaces on both sides thereof are covered by an organic-inorganic composite ultrafine fiber porous film. It is composed of bioglass particles that promote soft tissue regeneration and repair and inorganic mineral particles that inhibit inflammation and promote bone regeneration and repair. The bandage is prepared by three-dimensional printing and electrospinning technology, which is easy to operate and is suitable for muscles, periosteum, bones, etc. of various fractures or bone defects. The inflammation in the soft and hard tissues has a significant inhibitory effect, and it promotes the rapid healing and repair of the soft and hard tissues. The degradation rate of the implantable bandage can be adjusted, and it has a significant bacteriostatic effect on common pathogens and fungi.
本发明具有的有益效果体现在:The beneficial effects that the present invention has are embodied in:
1)在组成上,采用常规工艺合成的介孔生物玻璃微粒和完全或部分晶态无机矿物微粒,所含多元无机功能离子接触组织液会缓慢降解,释放出的离子组合物是人体生理代谢或者组织再生修复必需的矿物质,不存在严重影响软、硬组织再生细胞相容性的离子成分,同时某些离子还非常显著地表现出抗炎性、抗有害菌活性和/或促进血管化等效应,因而可以防范各种风险并发挥组织修复刺激活性作用。1) In terms of composition, the mesoporous bioglass particles and fully or partially crystalline inorganic mineral particles synthesized by conventional technology will slowly degrade in contact with tissue fluid, and the released ion composition is the physiological metabolism of human body or tissue. Minerals necessary for regeneration and repair, there are no ion components that seriously affect the cytocompatibility of soft and hard tissue regeneration, and some ions also significantly exhibit anti-inflammatory, anti-harmful bacteria activity and/or promote vascularization and other effects , so it can prevent various risks and play the role of tissue repair stimulating activity.
2)在(微)结构上,两种有机-无机复合超细纤维多孔膜覆盖于聚合物多孔网格两个表面,其多孔性特征不仅部分阻隔了来自软组织损伤内炎性反应甚至软组织介入到骨损伤内,并为骨损伤断端提供营养提供了孔道,同时绷带表面的超细纤维微纳结构也极其有利于骨膜再生相关干细胞的粘附和生长,为加快骨膜再生重建提供了良好支架。2) In terms of (micro) structure, two organic-inorganic composite microfiber porous membranes cover the two surfaces of the polymer porous grid, and their porosity not only partially blocks the inflammatory response from soft tissue injury and even the involvement of soft tissue. In addition, the ultra-fine fiber micro-nano structure on the surface of the bandage is also extremely conducive to the adhesion and growth of periosteal regeneration-related stem cells, providing a good scaffold for accelerating periosteal regeneration and reconstruction.
3)在生物学效应上,以具有高效抗炎、抗感染并促进软、硬组织愈合一体的协同增效生物学效应,是基于人体矿物质和微量元素协同构筑的可生物降解性生物玻璃微粒和无机矿物微粒,通过有机纤维体负载后与肌肉、骨骼创伤分别接触时,由其逐渐降解释放的多元功能离子快速消炎、抗菌,为创面组织再生愈合创造良好条件,实现骨创伤中肌肉、骨膜和骨骼均高效愈合或再生修复,同步解决严重骨损伤(骨折、骨缺损)病例中愈合延迟、畸形愈合甚至不修复等问题。3) In terms of biological effects, it is a biodegradable bioglass particle based on the synergistic construction of human minerals and trace elements with the synergistic biological effect of highly effective anti-inflammatory, anti-infection and promoting the healing of soft and hard tissues. and inorganic mineral particles, when loaded by organic fibers and contact with muscle and bone wounds, the multifunctional ions released by their gradual degradation can quickly reduce inflammation and antibacterial, create good conditions for wound tissue regeneration and healing, and realize muscle and periosteum in bone wounds. Both the bone and the bone are efficiently healed or repaired, and the problems of delayed healing, malunion or even non-repair in cases of severe bone injury (fracture, bone defect) are simultaneously solved.
4)在制备工艺及临床应用可操作性上,可以应用三维打印、静电纺丝等工艺制备片状聚合物多孔网格和有机-无机复合超细纤维网络薄膜,并采用三层结构依次叠加制造,从而构建出促进骨损伤修复的植入绷带材料。同时,该类片状多孔性绷带可以直接环绕覆盖于骨损伤表面,然后再利用受损的肌肉组织包裹,无需过度包扎,有效解决软、硬组织接触界面区营养传递和组织自身愈合修复问题。4) In terms of preparation process and clinical application operability, 3D printing, electrospinning and other processes can be used to prepare sheet-like polymer porous grids and organic-inorganic composite ultrafine fiber network films, and the three-layer structure can be used to superimpose one by one. , thereby constructing an implanted bandage material that promotes the repair of bone damage. At the same time, this type of sheet-like porous bandage can be directly wrapped around and covered on the surface of bone injury, and then wrapped with damaged muscle tissue without excessive bandaging, effectively solving the problems of nutrient transfer in the contact interface area between soft and hard tissues and tissue self-healing and repairing.
因此,这种进骨损伤修复的植入绷带材料显著的特征是:材料的制备工艺简单,能根据骨损伤部位进行剪裁和准确覆盖;能高效消炎、有效防控创面病菌感染,并促进软、硬组织愈合,避免骨损伤创面感染和延迟愈合等问题,极大地改进了骨损伤愈合、修复的施治策略,避免了常规的内外固定和营养摄入等缺乏对创伤部位直接活性刺激。Therefore, the significant features of this implanted bandage material for bone-injury repair are: the preparation process of the material is simple, the material can be tailored and accurately covered according to the bone injury site; it can efficiently reduce inflammation, effectively prevent and control wound surface bacterial infection, and promote soft, Hard tissue heals, avoids problems such as infection and delayed healing of bone injury wounds, greatly improves the treatment strategy for bone injury healing and repair, and avoids conventional internal and external fixation and nutritional intake.
附图说明Description of drawings
图1是植入绷带材料制备过程流程图。Fig. 1 is a flow chart of the preparation process of implanted bandage material.
图2是植入绷带材料的超细纤维多孔网络扫描图,其中图2中的A和图2中的B为含生物玻璃微粒的超细纤维膜,图2中的C为孔道内区域含无机矿物微粒的超细纤维膜,图2中的D为多孔网格骨架上的含无机矿物微粒的超细纤维膜。Fig. 2 is the scanning diagram of the microfiber porous network implanted in the bandage material, wherein A in Fig. 2 and B in Fig. 2 are the microfiber membranes containing bioglass particles, and C in Fig. Microfiber membrane of mineral particles, D in Figure 2 is a microfiber membrane containing inorganic mineral particles on a porous grid skeleton.
图3是植入绷带材料的超细纤维多孔网络透射电镜图,其中图3中的A为含生物玻璃微粒的超细纤维膜,图3中的B为含无机矿物微粒的超细纤维膜。Figure 3 is a transmission electron microscope image of the microfiber porous network implanted in the bandage material, wherein A in Figure 3 is a microfiber membrane containing bioglass particles, and B in Figure 3 is a microfiber membrane containing inorganic mineral particles.
图4是植入绷带材料的生物玻璃组分抑制金黄色葡萄球菌情况结果图。Figure 4 is a graph showing the results of the inhibition of Staphylococcus aureus by the bioglass component implanted in the bandage material.
图5是植入绷带材料在骨膜-骨创伤合并损伤模型上的组织愈合效果图。Fig. 5 is a graph showing the tissue healing effect of implanted bandage material on a combined injury model of periosteum-bone trauma.
具体实施方式Detailed ways
下面结合实施例进一步阐明本发明的内容,但这些实施例并不限制本发明的范围,凡基于本发明上述内容所实现的技术和制备的材料均属于本发明的保护范围。实施例所使用试剂纯度均不低于其分析纯试剂纯度指标。The content of the present invention is further clarified below in conjunction with the examples, but these examples do not limit the scope of the present invention, and all technologies and materials prepared based on the above-mentioned content of the present invention all belong to the protection scope of the present invention. The purity of the reagents used in the examples is not lower than the purity index of the analytical reagents.
本发明的实施例如下:Embodiments of the present invention are as follows:
实施例1:0.04~8μm,所述的无机矿物微粒的颗粒度为0.02~40μm。Example 1: 0.04-8 μm, the particle size of the inorganic mineral particles is 0.02-40 μm.
1)将颗粒度为0.15~0.85μm的介孔生物玻璃纳米粉体(化学组成为28Ca O-42SiO2-12B2O3-4P2O5-6MgO-1CuO-2ZnO-4Na2O-1K2O)加入到质量之比为1:9的透明质酸-明胶复合水溶液中搅拌均匀,生物玻璃与有机物的质量比为1:20,配制成生物玻璃浓度为50mg/ml的有机-无机复合物溶液,然后转移到静电纺丝的储液器中,设置纺丝间距为15cm,纺丝电压为16kV下,按0.4毫升/小时的速度进行静电纺丝,然后收集多孔铜箔载体上厚度为200微米水平的超细纤维多孔薄膜;1) Mesoporous bioglass nanopowder (chemical composition: 28CaO - 42SiO2-12B2O3-4P2O5-6MgO - 1CuO - 2ZnO - 4Na2O - 1K2) with a particle size of 0.15-0.85μm O) Add to the hyaluronic acid-gelatin composite aqueous solution with a mass ratio of 1:9 and stir evenly, the mass ratio of bioglass to organic matter is 1:20, and prepare an organic-inorganic composite with a bioglass concentration of 50 mg/ml The solution was then transferred to the electrospinning reservoir, the spinning distance was set to 15 cm, the spinning voltage was 16 kV, and electrospinning was carried out at a speed of 0.4 ml/hour, and then the porous copper foil carrier was collected on a porous copper foil carrier with a thickness of 200. Micron-level microfiber porous membrane;
2)将用于制备聚L-丙交酯-己内酯多孔网格的有机物直接置入三维打印机的物料器中,采用加热软化聚合物并进行挤压出打印喷头,以步骤1)形成的超细纤维多孔薄膜为基质进行三维打印聚合物多孔网格,多孔网格的正方形微孔的尺度为650微米,打印多孔网格的厚度为200~1200微米;2) The organic substance used for preparing the poly-L-lactide-caprolactone porous mesh is directly placed in the material container of the three-dimensional printer, and the polymer is softened by heating and extruded out of the printing nozzle, and the result is formed in step 1). The microfiber porous film is used as the matrix for three-dimensional printing of polymer porous grids, the size of the square pores of the porous grids is 650 microns, and the thickness of the printed porous grids is 200-1200 microns;
3)将颗粒度为0.02~0.08μm的无机矿物微粒(所含无机离子和酸根离子的摩尔百分数分别为SiO3 2-45%,PO4 3-5%,Ca2+40%,Mg2+4%,Zn2+2%,Cu2+0.6%,Sr2+2%,Na+1.4%)加入到质量之比为1:3的壳聚糖-明胶水溶液中搅拌均匀,超细微粒与溶液中有机物的质量比为1:8,配制成超细颗粒物浓度为30mg/ml的复合物溶液,然后进行复合物溶液静电纺丝,将超细纤维沉积在步骤2)制备的聚合物多孔网格上,纺丝间距为12cm,纺丝电压为18kV,纺丝速度为0.5毫升/小时,形成厚度为800微米的超细纤维多孔薄膜。3) Inorganic mineral particles with a particle size of 0.02-0.08 μm (the mole percentages of inorganic ions and acid ions contained are SiO 3 2-45%, PO 4 3- 5 %, Ca 2+ 40%, Mg 2+ 4%, Zn 2+ 2%, Cu 2+ 0.6%, Sr 2+ 2%, Na + 1.4%) were added to the chitosan-gelatin aqueous solution with a mass ratio of 1:3 and stirred well, and the ultrafine particles were mixed with The mass ratio of organic matter in the solution is 1:8, and it is prepared into a composite solution with an ultrafine particle concentration of 30 mg/ml, and then electrospinning of the composite solution is performed to deposit ultrafine fibers on the polymer porous network prepared in step 2). On the grid, the spinning distance was 12 cm, the spinning voltage was 18 kV, and the spinning speed was 0.5 ml/hour to form a microfiber porous film with a thickness of 800 microns.
上述步骤的制备过程流程如附图1所示,形成中间层为聚L-丙交酯-己内酯多孔网格以及下层、上层均为透明质酸-明胶-生物玻璃、壳聚糖-明胶-异质离子共掺杂钙镁硅酸盐陶瓷复合电纺纤维多孔网络的可植入骨损伤愈合绷带材料。附图2和图3分别为超细纤维网络的扫描电镜和透射电镜照片,均可见生物玻璃或无机矿物微粒附着于纤维体中。The preparation process flow of the above steps is shown in accompanying drawing 1, and the intermediate layer is a poly-L-lactide-caprolactone porous grid, and the lower layer and the upper layer are hyaluronic acid-gelatin-bioglass, chitosan-gelatin - Heterogeneous ion co-doped calcium magnesium silicate ceramic composite electrospun fiber porous network implantable bone injury healing bandage material. Figures 2 and 3 are the scanning electron microscope and transmission electron microscope photographs of the ultrafine fiber network, respectively, and it can be seen that the bioglass or inorganic mineral particles are attached to the fiber body.
实施例2:Example 2:
1)将颗粒度为0.50~1.20μm的介孔生物玻璃微粒(化学组成为24CaO-48SiO2-12B2O3-2P2O5-6MgO-4ZnO-4Na2O)加入到质量之比为2:5的海藻酸钠-明胶复合溶液中搅拌均匀,超细微粒与有机物的质量比为1:15,配制成超细颗粒物浓度为20mg/ml的有机-无机复合物溶液,然后转移到静电纺丝的储液器中,设置纺丝间距为18cm,纺丝电压为18kV下,按0.3毫升/小时的速度进行静电纺丝,然后收集铝箔载体上厚度为150微米水平的超细纤维多孔薄膜;1) Add mesoporous bioglass particles with a particle size of 0.50 to 1.20 μm (chemical composition: 24CaO-48SiO 2 -12B 2 O 3 -2P 2 O 5 -6MgO-4ZnO-4Na 2 O) to a mass ratio of 2 : 5 sodium alginate-gelatin composite solution, stir evenly, the mass ratio of ultrafine particles to organic matter is 1:15, prepare an organic-inorganic composite solution with ultrafine particles concentration of 20mg/ml, and then transfer to electrospinning In the liquid reservoir of the silk, set the spinning distance to 18 cm and the spinning voltage to 18 kV, perform electrospinning at a speed of 0.3 ml/hour, and then collect the microfiber porous film with a thickness of 150 microns on the aluminum foil carrier;
2)将用于制备聚己内酯多孔网格的有机物直接置入三维打印机的物料器中,采用加热软化聚合物并进行挤压出打印喷头,以步骤1)形成的超细纤维多孔薄膜为基质进行三维打印聚合物多孔网格,多孔网格的六边形孔尺度为650微米,打印后的聚合物多孔网格厚度为800微米;2) The organic substance used to prepare the polycaprolactone porous grid is directly placed in the material container of the three-dimensional printer, and the polymer is softened by heating and extruded out of the printing nozzle. The microfiber porous film formed in step 1) is The matrix is three-dimensionally printed with a polymer porous grid, the hexagonal hole size of the porous grid is 650 microns, and the thickness of the printed polymer porous grid is 800 microns;
3)将颗粒度为0.4~1.6μm的无机矿物微粒(所含无机离子和酸根离子的摩尔百分数分别为SiO3 2-42%,PO4 3-8%,Ca2+38%,Mg2+6%,Zn2+2%,Na+4%)加入到质量之比为1:6的壳聚糖-明胶溶液中搅拌均匀,超细微粒与溶液中有机物的质量比为1:10,配制成超细颗粒物浓度为60mg/ml的复合物溶液,然后进行复合物溶液静电纺丝,将超细纤维沉积在步骤2)制备的聚合物多孔网格上,纺丝间距为16cm,纺丝电压为12kV,纺丝速度为0.4毫升/小时,形成厚度为600微米的超细纤维多孔薄膜。3) Inorganic mineral particles with a particle size of 0.4-1.6 μm (the mole percentages of inorganic ions and acid ions contained are SiO 3 2-42%, PO 4 3- 8 %, Ca 2+ 38%, Mg 2+ 6%, Zn 2+ 2%, Na + 4%) was added to the chitosan-gelatin solution with a mass ratio of 1:6 and stirred evenly, and the mass ratio of ultrafine particles to organic matter in the solution was 1:10. A composite solution with an ultrafine particle concentration of 60 mg/ml was obtained, and then electrospinning of the composite solution was performed, and the ultrafine fibers were deposited on the polymer porous grid prepared in step 2), the spinning distance was 16 cm, and the spinning voltage At 12 kV, the spinning speed was 0.4 ml/hour, and a microfiber porous film with a thickness of 600 μm was formed.
上述步骤的制备形成中间层为聚己内酯多孔网格以及下层、上层均为海藻酸钠-明胶-生物玻璃、壳聚糖-明胶-异质离子共掺杂钙磷酸盐陶瓷复合电纺纤维多孔网络的可植入骨损伤愈合绷带材料。The preparation of the above steps forms the middle layer as a polycaprolactone porous mesh, and the lower layer and the upper layer are sodium alginate-gelatin-bioglass, chitosan-gelatin-hetero ion co-doped calcium phosphate ceramic composite electrospinning fibers Implantable Bone Injury Healing Bandage Materials of Porous Networks.
实施例3:Example 3:
1)将颗粒度为0.32~1.10μm的介孔生物玻璃粉体(24CaO-56SiO2-8B2O3-4MgO-2ZnO-6Na2O)加入到质量之比为2:8:1的海藻酸钠-明胶-聚乙烯磷酸复合有机物溶液中搅拌均匀,超细微粒与有机物的质量比为1:15,配制成超细颗粒物浓度为20mg/ml的有机-无机复合物溶液,然后转移到静电纺丝的储液器中,设置纺丝间距为16cm,纺丝电压为20kV下,按0.4毫升/小时的速度进行静电纺丝,然后收集铝箔转筒载体上厚度为280微米水平的超细纤维多孔薄膜;1) Add mesoporous bioglass powder (24CaO-56SiO 2 -8B 2 O 3 -4MgO-2ZnO-6Na 2 O) with a particle size of 0.32 to 1.10 μm to alginic acid with a mass ratio of 2:8:1 The sodium-gelatin-polyvinylphosphoric acid composite organic solution was stirred evenly, the mass ratio of ultrafine particles to organics was 1:15, and the organic-inorganic composite solution with ultrafine particles concentration of 20 mg/ml was prepared, and then transferred to electrospinning In the silk liquid reservoir, set the spinning distance to 16 cm and the spinning voltage to 20 kV, perform electrospinning at a speed of 0.4 ml/hour, and then collect the ultrafine fibers with a thickness of 280 microns on the aluminum foil drum carrier. film;
2)将用于制备羧甲基纤维素钠多孔网格的有机物直接置入三维打印机的物料器中,采用加热软化聚合物并进行挤压出打印喷头,以步骤1)形成的超细纤维多孔薄膜为基质进行三维打印聚合物多孔网格,多孔网格的孔道为圆形,孔直径为800微米,打印后聚合物多孔网格厚度为400微米;2) The organic matter used to prepare the sodium carboxymethyl cellulose porous grid is directly placed in the material container of the three-dimensional printer, and the polymer is softened by heating and extruded out of the printing nozzle, and the microfiber porous mesh formed in step 1) is used. The film is used as the substrate for three-dimensional printing of polymer porous grids. The pores of the porous grids are circular, the pore diameter is 800 microns, and the thickness of the polymer porous grids after printing is 400 microns;
3)将颗粒度为0.02~1.80μm的无机矿物微粒(所含无机离子和酸根离子的摩尔百分数分别为SiO3 2-4%,PO4 3-36%,Ca2+46%,Mg2+6%,Zn2+2%,结晶水为6%)加入到质量之比为1:3的壳聚糖-明胶溶液中搅拌均匀,超细微粒与溶液中有机物的质量比为1:10,配制成超细颗粒物浓度为80mg/ml的复合物溶液,然后进行复合物溶液静电纺丝,将超细纤维沉积在步骤2)制备的聚合物多孔网格上,纺丝间距为16cm,纺丝电压为16kV,纺丝速度为0.6毫升/小时,形成厚度为400微米的超细纤维多孔薄膜。3) Inorganic mineral particles with a particle size of 0.02 to 1.80 μm (the mole percentages of inorganic ions and acid ions contained are SiO 3 2-4%, PO 4 3- 36%, Ca 2+ 46%, Mg 2+ 6%, Zn 2+ 2%, crystallization water 6%) was added to the chitosan-gelatin solution with a mass ratio of 1:3 and stirred evenly, and the mass ratio of ultrafine particles to organic matter in the solution was 1:10, Prepare a composite solution with an ultrafine particle concentration of 80 mg/ml, and then perform electrospinning of the composite solution, depositing ultrafine fibers on the polymer porous grid prepared in step 2), the spinning distance is 16cm, spinning The voltage was 16 kV, and the spinning speed was 0.6 ml/hour to form a microfiber porous film with a thickness of 400 μm.
上述步骤的制备形成中间层为聚己内酯多孔网格以及下层、上层均为海藻酸钠-明胶-聚乙烯磷酸-生物玻璃、壳聚糖-明胶-异质离子共掺杂钙镁硅酸盐陶瓷复合电纺纤维多孔网络的可植入骨损伤愈合绷带材料。The preparation of the above steps forms the intermediate layer as a polycaprolactone porous grid, and the lower layer and the upper layer are sodium alginate-gelatin-polyvinylphosphoric acid-bioglass, chitosan-gelatin-hetero ion co-doped calcium magnesium silicic acid Implantable Bone Injury Healing Bandage Materials of Salt-Ceramic Composite Electrospun Fiber Porous Networks.
实施例4:Example 4:
1)将颗粒度为0.2~0.8μm的介孔生物玻璃微粒(化学组成为24CaO-50SiO2-18B2O3-6MgO-2ZnO)加入到质量之比为8:2的海藻酸钠-明胶-聚乙烯磷酸复合有机物溶液中搅拌均匀,超细微粒与有机物的质量比为1:10,配制成超细颗粒物浓度为20mg/ml的有机-无机复合物溶液,然后转移到静电纺丝的储液器中,设置纺丝间距为12cm,纺丝电压为14kV下,按0.3毫升/小时的速度进行静电纺丝,然后收集铝箔转筒上厚度为200微米水平的超细纤维多孔薄膜;1) Add mesoporous bioglass particles (chemical composition: 24CaO-50SiO 2 -18B 2 O 3 -6MgO-2ZnO) with a particle size of 0.2 to 0.8 μm to sodium alginate-gelatin- The polyvinylphosphoric acid composite organic solution was stirred evenly, the mass ratio of ultrafine particles to organics was 1:10, and the organic-inorganic composite solution with ultrafine particles concentration of 20 mg/ml was prepared, and then transferred to the electrospinning storage solution In the device, set the spinning distance to 12cm and the spinning voltage to 14kV, perform electrospinning at a speed of 0.3ml/hour, and then collect the microfiber porous film with a thickness of 200 microns on the aluminum foil drum;
2)将用于制备聚乳酸多孔网格的有机物直接置入三维打印机的物料器中,采用加热软化聚合物并进行挤压出打印喷头,以步骤1)形成的超细纤维多孔薄膜为基质进行三维打印聚合物多孔网格,多孔网格的长方形孔尺度为400×600微米,打印的聚合物多孔网格厚度为600微米;2) The organic substance used for preparing the polylactic acid porous grid is directly placed in the material container of the three-dimensional printer, and the polymer is softened by heating and extruded out of the printing nozzle, and the microfiber porous film formed in step 1) is used as the matrix. Three-dimensional printing of polymer porous grids, the size of the rectangular pores of the porous grids is 400 × 600 microns, and the thickness of the printed polymer porous grids is 600 microns;
3)将颗粒度为0.6~1.20μm的无机矿物微粒(所含无机离子和酸根离子的摩尔百分数分别为SiO3 2-40%,PO4 3-10%,Ca2+34%,Mg2+10%,Zn2+2%,Sr2+4%)加入到质量之比为1:3的羧甲基壳聚糖-明胶溶液中搅拌均匀,超细微粒与溶液中有机物的质量比为1:10,配制成超细颗粒物浓度为60mg/ml的复合物溶液,然后进行复合物溶液静电纺丝,将超细纤维沉积在步骤2)制备的聚合物多孔网格上,纺丝间距为18cm,纺丝电压为12kV,纺丝速度为0.5毫升/小时,形成厚度为400微米的超细纤维多孔薄膜。3) Inorganic mineral particles with a particle size of 0.6-1.20 μm (the mole percentages of inorganic ions and acid ions contained are SiO 3 2-40 %, PO 4 3- 10%, Ca 2+ 34%, Mg 2+ 10%, Zn 2+ 2%, Sr 2+ 4%) was added to the carboxymethyl chitosan-gelatin solution with a mass ratio of 1:3 and stirred evenly, and the mass ratio of ultrafine particles to organic matter in the solution was 1 : 10, prepare a composite solution with an ultrafine particle concentration of 60 mg/ml, and then perform electrospinning of the composite solution, depositing ultrafine fibers on the polymer porous grid prepared in step 2), and the spinning distance is 18cm , the spinning voltage was 12 kV, and the spinning speed was 0.5 ml/hour to form a microfiber porous film with a thickness of 400 μm.
上述步骤的制备形成中间层为聚乳酸多孔网格以及下层、上层分别为海藻酸钠-明胶-聚乙烯磷酸-生物玻璃、羧甲基壳聚糖-明胶-异质离子共掺杂钙镁硅酸盐陶瓷复合电纺纤维多孔网络的可植入骨损伤愈合绷带材料。The preparation of the above steps forms the middle layer as a polylactic acid porous grid, and the lower layer and the upper layer are respectively sodium alginate-gelatin-polyvinylphosphoric acid-bioglass, carboxymethyl chitosan-gelatin-hetero ion co-doped calcium magnesium silicon Implantable Bone Injury Healing Bandage Material with Electrospun Fiber Porous Networks of Salt-Ceramic Composites.
实施例5~13:Examples 5 to 13:
类似实施例1的制备步骤,实施例5~13中的介孔生物玻璃、无机矿物微粒和聚合物多孔网格的组成如下表格,其它同实施例1,得到可植入骨损伤愈合绷带材料。Similar to the preparation steps of Example 1, the compositions of the mesoporous bioglass, inorganic mineral particles and polymer porous meshes in Examples 5 to 13 are as follows, and the others are the same as those of Example 1, to obtain implantable bone injury healing bandage materials.
实施例的试验验证:Experimental verification of the embodiment:
1、抑菌试验1. Antibacterial test
将实施例1、实施例2、实施例3的绷带材料剪裁为直径为10mmm片状物,不经灭菌就加入到分别接种金黄色葡萄球菌的表面皿中等距放置,在厌氧环境下继续培养8-24小时,观察抑菌环形成情况。如附图4的结果显示,绷带材料对这种细菌的生长具有明显的抑制作用,在8、16和24小时时抑菌率均不低于75%~99%。The bandage materials of Example 1, Example 2, and Example 3 were cut into sheets with a diameter of 10 mm, added to the watch dishes inoculated with Staphylococcus aureus respectively without sterilization, and placed at a distance, and continued in an anaerobic environment. Incubate for 8-24 hours, and observe the formation of the bacteriostatic ring. As shown in the results of FIG. 4 , the bandage material has a significant inhibitory effect on the growth of this bacteria, and the antibacterial rate is not less than 75% to 99% at 8, 16 and 24 hours.
2、糖尿病动物股骨缺损修复实验2. Femoral defect repair experiment in diabetic animals
取糖尿病成年新西兰大白兔活体动物模型,体重为2.5kg左右,静脉注射戊巴比妥钠,麻醉后仰面固定于手术台上。剥离股骨骨膜,并对股骨干皮质骨进行切割,同时剪裁取出部分骨膜,然后覆盖实施例1和实施例2的植入绷带材料,对照组1和2分别为创伤修复用纯壳聚糖膜和明胶膜,按常规步骤缝合创面和术后管理。试验结果显示,在此期间所有动物生命体征良好,存活率100%;如附图5所示,术后6周时股骨干骨膜-股骨皮质骨缺损部位愈合良好,尤其实施例1时骨膜完全修复,骨膜血管化程度高,皮质骨部分也完全愈合,对照组的骨膜修复效率较低。由此实验可见,本发明的植入绷带材料对软硬组织同步修复的能力优良。A living animal model of diabetic adult New Zealand white rabbits, weighing about 2.5 kg, was injected intravenously with sodium pentobarbital, and fixed on the operating table after anesthesia. The femoral periosteum was peeled off, the femoral shaft cortical bone was cut, and part of the periosteum was cut out, and then covered with the implanted bandage materials of Example 1 and Example 2. Control groups 1 and 2 were pure chitosan film for wound repair and Gelatin film, suture wounds and postoperative management according to routine procedures. The test results showed that all animals had good vital signs during this period, and the survival rate was 100%; as shown in Figure 5, the femoral shaft periosteum-femoral cortical bone defect healed well 6 weeks after the operation, especially in Example 1, the periosteum was completely repaired. , the degree of periosteal vascularization was high, and the cortical bone was partially healed, and the repair efficiency of the periosteum was lower in the control group. From this experiment, it can be seen that the implanted bandage material of the present invention has excellent ability to simultaneously repair soft and hard tissues.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110379089.7A CN113171224B (en) | 2021-04-08 | 2021-04-08 | An implanted bandage for promoting bone injury repair and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110379089.7A CN113171224B (en) | 2021-04-08 | 2021-04-08 | An implanted bandage for promoting bone injury repair and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113171224A CN113171224A (en) | 2021-07-27 |
CN113171224B true CN113171224B (en) | 2022-06-28 |
Family
ID=76924771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110379089.7A Active CN113171224B (en) | 2021-04-08 | 2021-04-08 | An implanted bandage for promoting bone injury repair and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113171224B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114191615B (en) * | 2021-12-21 | 2022-07-08 | 浙江大学 | Multilayer composite material for promoting repair of articular cartilage-calcified layer-subchondral bone and preparation method thereof |
CN114392396B (en) * | 2022-01-19 | 2022-10-28 | 福州市第二医院(福建省福州中西医结合医院、福州市职业病医院) | Rotator cuff patch based on silk fibroin gel and preparation method thereof |
CN116354599A (en) * | 2023-04-06 | 2023-06-30 | 深圳先进技术研究院 | Boron-containing bioactive glass and preparation method and application thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1878514A (en) * | 2003-11-20 | 2006-12-13 | 血管技术国际股份公司 | Soft tissue implants and anti-scarring agents |
US7862835B2 (en) * | 2004-10-27 | 2011-01-04 | Boston Scientific Scimed, Inc. | Method of manufacturing a medical device having a porous coating thereon |
CN101288780B (en) * | 2008-06-10 | 2011-05-25 | 浙江大学 | Degradable mechanically enhanced bioglass-based porous composite material and preparation method thereof |
CN101507841B (en) * | 2009-03-30 | 2012-11-07 | 西南交通大学 | Preparation method of inorganic calcium phosphate salt/biodegradable polymer fiber film composite material |
US10166128B2 (en) * | 2011-01-14 | 2019-01-01 | W. L. Gore & Associates. Inc. | Lattice |
CN106039424B (en) * | 2016-05-25 | 2019-04-05 | 南京凤源新材料科技有限公司 | A kind of novel polylactic acid glass fiber composite material for skeletal fixation |
US20190269828A1 (en) * | 2016-07-25 | 2019-09-05 | Ube Industries, Ltd. | Implant and kit for treatment of bone lesion site, as well as method for treating bone lesion site |
EP3470097B1 (en) * | 2017-10-16 | 2021-03-31 | Arctic Biomaterials Oy | Orthopedic bioabsorbable implants |
CN108379658B (en) * | 2018-02-06 | 2021-03-02 | 中国科学院金属研究所 | Orthopedic implant device with copper-containing coating and preparation method thereof |
CN111437440A (en) * | 2020-04-02 | 2020-07-24 | 杭州鹿扬科技有限公司 | Controllable degradable bone implantation composite material and preparation method thereof |
-
2021
- 2021-04-08 CN CN202110379089.7A patent/CN113171224B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN113171224A (en) | 2021-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113171224B (en) | An implanted bandage for promoting bone injury repair and preparation method thereof | |
CN113456885B (en) | A kind of gradient material for promoting the repair of cartilage calcification layer and preparation method | |
Kargozar et al. | Can bioactive glasses be useful to accelerate the healing of epithelial tissues? | |
Wu et al. | Mesoporous bioactive glasses: Structure characteristics, drug/growth factor delivery and bone regeneration application | |
US9795716B2 (en) | Resorbable ceramics with controlled strength loss rates | |
CN110665063A (en) | 3D biological printing ink and preparation method thereof, tissue engineering scaffold and preparation method thereof | |
HK1041803A1 (en) | Anti-inflammatory and antimicrobial uses for bioactive glass compositions | |
EP2448607A1 (en) | A bioactive glass for use in conditions relating to bone infections | |
CN107149698A (en) | Material of bio-compatible and application thereof | |
Xiao et al. | Fishnet-inspired 3D scaffold fabricated from mesh-like electrospun membranes promoted osteoporotic bone regeneration | |
EP2080528B1 (en) | Preparation for regeneration of postoperative and post-traumatic bone defects | |
Wang et al. | Simultaneous enhancement of vascularization and contact-active antibacterial activity in diopside-based ceramic orbital implants | |
CN114404656A (en) | Core-shell structure fiber functional inorganic biomaterial, preparation method and application | |
Ma et al. | Enhanced osteogenic activity and bone repair ability of PLGA/MBG scaffolds doped with ZIF-8 nanoparticles loaded with BMP-2 | |
CN110585487A (en) | Medical periosteum scaffold loaded with ions and geometric pattern signals and construction method thereof | |
CN107129157A (en) | A kind of preparation method of three-dimensional porous bioactivity glass | |
Majumdar et al. | Multifarious applications of bioactive glasses in soft tissue engineering | |
CN111773432A (en) | Magnesium-based amorphous-calcium phosphate/calcium silicate composite filler and its preparation and application | |
Pang et al. | In vitro and in vivo evaluation of biomimetic hydroxyapatite/whitlockite inorganic scaffolds for bone tissue regeneration | |
CN111973810B (en) | Porous hollow tubular material for regeneration, repair and reconstruction of large segmental bone defect of limbs and preparation method | |
Suruagy et al. | Physico-chemical and histomorphometric evaluation of zinc-containing hydroxyapatite in rabbits calvaria | |
CN102430147B (en) | Biodegradable strontium-doped calcium sulfate material having biological activity, and its preparation method and use | |
Gala-García et al. | In vitro and in vivo evaluation of the biocompatibility of a calcium phosphate/poly (lactic-co-glycolic acid) composite | |
Miguez-Pacheco et al. | Bioactive glasses for soft tissue engineering applications | |
CN115501396B (en) | Degradable tissue scaffold and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |